China's middleclass prefers European drugs
The Chinese population prefers European medicine to locally produced drugs. This interest, combined with the increasing wealth of the middleclass, has created a billion-dollar business for Danish Novo Nordisk.
In 1962, Novo Nordisk launched its first products in China. 25 years ago, in 1994, the Danish drug group established its Chinese office, Novo Nordisk Biotech Co. But the real breakthrough in the populous country happened after the turn of the millenium.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
